Financials data is unavailable for this security.
View more
Year on year ConvaTec Group PLC grew revenues 3.37% from 2.07bn to 2.14bn while net income improved 107.15% from 62.90m to 130.30m.
Gross margin | 56.04% |
---|---|
Net profit margin | 6.08% |
Operating margin | 12.35% |
Return on assets | 3.57% |
---|---|
Return on equity | 7.89% |
Return on investment | 4.18% |
More ▼
Cash flow in USDView more
In 2023, cash reserves at ConvaTec Group PLC fell by 46.20m. However, the company earned 367.40m from its operations for a Cash Flow Margin of 17.15%. In addition the company used 285.70m on investing activities and also paid 124.00m in financing cash flows.
Cash flow per share | 0.1342 |
---|---|
Price/Cash flow per share | 18.25 |
Book value per share | 0.6593 |
---|---|
Tangible book value per share | -0.2109 |
More ▼
Balance sheet in USDView more
Current ratio | 1.62 |
---|---|
Quick ratio | 0.8835 |
Total debt/total equity | 0.7753 |
---|---|
Total debt/total capital | 0.4367 |
More ▼
Growth rates in USD
Year on year, both dividends per share and earnings per share excluding extraordinary items growth increased 9.77% and 105.90%, respectively. The positive trend in dividend payments is noteworthy since very few companies in the Medical Equipment & Supplies industry pay a dividend. Additionally when measured on a five year annualized basis, dividend per share growth ranked highest relative to its industry peers, while earnings per share growth is in-line with the industry average.
Div yield(5 year avg) | 2.19% |
---|---|
Div growth rate (5 year) | 31.41% |
Payout ratio (TTM) | 70.15% |
EPS growth(5 years) | -7.80 |
---|---|
EPS (TTM) vs TTM 1 year ago | 105.40 |
More ▼